Cardiometabolic Risk in Children With Type 1 Diabetes.

Association Between Metabolic Control and Cardiometabolic Risk in Children With Type 1 Diabetes.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03544541

Enrollment

150

Registered

2018-06-01

Start date

2018-01-05

Completion date

2019-11-30

Last updated

2020-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Complication, Type1 Diabetes Mellitus

Brief summary

To access the relationship between metabolic control of children and adolescents with type 1 diabetes and cardiometabolic risk through noninvasive imaging modalities to assess the early vasculature changes.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

10 Years to 25 Years

Inclusion criteria

* Type 1 diabetes for more than 0.5 year * Age ≥ 10 years up to 25 years (inclusive) * The subject/carer is willing to follow study specific instructions

Exclusion criteria

* Youth with maturity-onset diabetes of the young, hybrid, other, or missing type * Any significant diseases / conditions including psychiatric disorders and substance abuse that in the opinion of the investigator is likely to affect the subject's ability to complete the study * Current use of the following medications: medications that are used to lower blood glucose such as Pramlintide, Metformin and GLP-1 analogs. Beta blockers, glucocorticoids and other medications, which in the judgment of the investigator would be a contraindication to participation in the study (Anticoagulant therapy e.g. Plavix, LMW heparin, Coumadin, Immunosuppressant therapy)

Design outcomes

Primary

Measure	Time frame	Description
Carotid Intima-Media Thickness	24 months	Non-invasive (Doppler Ultrasound) measurement of Carotid Intima-Media Thickness

Countries

Slovenia

Outcome results